Global Docetaxel Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Docetaxel Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 20 mg/ml
- 1.3.3 40 mg/ml
- 1.3.4 60 mg/ml
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Docetaxel Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Breast Cancer
- 1.4.3 Prostate Cancer
- 1.4.4 Non-small Cell Lung Cancer
- 1.4.5 Others
- 1.5 Global Docetaxel Market Size & Forecast
- 1.5.1 Global Docetaxel Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Docetaxel Sales Quantity (2020-2031)
- 1.5.3 Global Docetaxel Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Hengrui Medicine
- 2.1.1 Hengrui Medicine Details
- 2.1.2 Hengrui Medicine Major Business
- 2.1.3 Hengrui Medicine Docetaxel Product and Services
- 2.1.4 Hengrui Medicine Docetaxel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Hengrui Medicine Recent Developments/Updates
- 2.2 Sanofi
- 2.2.1 Sanofi Details
- 2.2.2 Sanofi Major Business
- 2.2.3 Sanofi Docetaxel Product and Services
- 2.2.4 Sanofi Docetaxel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Sanofi Recent Developments/Updates
- 2.3 Qilu Pharma
- 2.3.1 Qilu Pharma Details
- 2.3.2 Qilu Pharma Major Business
- 2.3.3 Qilu Pharma Docetaxel Product and Services
- 2.3.4 Qilu Pharma Docetaxel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Qilu Pharma Recent Developments/Updates
- 2.4 Shenzhen Main Luck Pharma
- 2.4.1 Shenzhen Main Luck Pharma Details
- 2.4.2 Shenzhen Main Luck Pharma Major Business
- 2.4.3 Shenzhen Main Luck Pharma Docetaxel Product and Services
- 2.4.4 Shenzhen Main Luck Pharma Docetaxel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Shenzhen Main Luck Pharma Recent Developments/Updates
- 2.5 Jiangsu Aosaikang Pharma
- 2.5.1 Jiangsu Aosaikang Pharma Details
- 2.5.2 Jiangsu Aosaikang Pharma Major Business
- 2.5.3 Jiangsu Aosaikang Pharma Docetaxel Product and Services
- 2.5.4 Jiangsu Aosaikang Pharma Docetaxel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Jiangsu Aosaikang Pharma Recent Developments/Updates
3 Competitive Environment: Docetaxel by Manufacturer
- 3.1 Global Docetaxel Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Docetaxel Revenue by Manufacturer (2020-2025)
- 3.3 Global Docetaxel Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Docetaxel by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Docetaxel Manufacturer Market Share in 2024
- 3.4.3 Top 6 Docetaxel Manufacturer Market Share in 2024
- 3.5 Docetaxel Market: Overall Company Footprint Analysis
- 3.5.1 Docetaxel Market: Region Footprint
- 3.5.2 Docetaxel Market: Company Product Type Footprint
- 3.5.3 Docetaxel Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Docetaxel Market Size by Region
- 4.1.1 Global Docetaxel Sales Quantity by Region (2020-2031)
- 4.1.2 Global Docetaxel Consumption Value by Region (2020-2031)
- 4.1.3 Global Docetaxel Average Price by Region (2020-2031)
- 4.2 North America Docetaxel Consumption Value (2020-2031)
- 4.3 Europe Docetaxel Consumption Value (2020-2031)
- 4.4 Asia-Pacific Docetaxel Consumption Value (2020-2031)
- 4.5 South America Docetaxel Consumption Value (2020-2031)
- 4.6 Middle East & Africa Docetaxel Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Docetaxel Sales Quantity by Type (2020-2031)
- 5.2 Global Docetaxel Consumption Value by Type (2020-2031)
- 5.3 Global Docetaxel Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Docetaxel Sales Quantity by Application (2020-2031)
- 6.2 Global Docetaxel Consumption Value by Application (2020-2031)
- 6.3 Global Docetaxel Average Price by Application (2020-2031)
7 North America
- 7.1 North America Docetaxel Sales Quantity by Type (2020-2031)
- 7.2 North America Docetaxel Sales Quantity by Application (2020-2031)
- 7.3 North America Docetaxel Market Size by Country
- 7.3.1 North America Docetaxel Sales Quantity by Country (2020-2031)
- 7.3.2 North America Docetaxel Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Docetaxel Sales Quantity by Type (2020-2031)
- 8.2 Europe Docetaxel Sales Quantity by Application (2020-2031)
- 8.3 Europe Docetaxel Market Size by Country
- 8.3.1 Europe Docetaxel Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Docetaxel Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Docetaxel Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Docetaxel Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Docetaxel Market Size by Region
- 9.3.1 Asia-Pacific Docetaxel Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Docetaxel Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Docetaxel Sales Quantity by Type (2020-2031)
- 10.2 South America Docetaxel Sales Quantity by Application (2020-2031)
- 10.3 South America Docetaxel Market Size by Country
- 10.3.1 South America Docetaxel Sales Quantity by Country (2020-2031)
- 10.3.2 South America Docetaxel Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Docetaxel Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Docetaxel Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Docetaxel Market Size by Country
- 11.3.1 Middle East & Africa Docetaxel Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Docetaxel Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Docetaxel Market Drivers
- 12.2 Docetaxel Market Restraints
- 12.3 Docetaxel Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Docetaxel and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Docetaxel
- 13.3 Docetaxel Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Docetaxel Typical Distributors
- 14.3 Docetaxel Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Docetaxel market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
China Docetaxel key players include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, etc. Top four companies hold a share over 80%. In terms of product, 20 mg/ml is the largest segment, with a share nearly 85%.
This report is a detailed and comprehensive analysis for global Docetaxel market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Docetaxel market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Docetaxel market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Docetaxel market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Docetaxel market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Docetaxel
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Docetaxel market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, Jiangsu Aosaikang Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Docetaxel market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg/ml
40 mg/ml
60 mg/ml
Market segment by Application
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Others
Major players covered
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Docetaxel product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Docetaxel, with price, sales quantity, revenue, and global market share of Docetaxel from 2020 to 2025.
Chapter 3, the Docetaxel competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Docetaxel breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Docetaxel market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Docetaxel.
Chapter 14 and 15, to describe Docetaxel sales channel, distributors, customers, research findings and conclusion.